LHC Group (LHCG)
(Delayed Data from NSDQ)
$114.82 USD
+2.44 (2.17%)
Updated May 3, 2019 04:00 PM ET
After-Market: $114.82 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$114.82 USD
+2.44 (2.17%)
Updated May 3, 2019 04:00 PM ET
After-Market: $114.82 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
GDRX or LHCG: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GDRX vs. LHCG: Which Stock Is the Better Value Option?
LHC Group's (LHCG) Q3 Earnings & Revenues Miss Estimates
by Zacks Equity Research
LHC Group's (LHCG) third-quarter results benefit from organic growth in hospice admissions. However, home health admissions decline organically.
LHC Group (LHCG) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
LHC (LHCG) delivered earnings and revenue surprises of -22.63% and 6.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate LHC Group (LHCG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LHC (LHCG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LHC Group's (LHCG) Latest Tie-Up to Improve Patient Services
by Zacks Equity Research
LHC Group's (LHCG) latest JV is expected to expand the availability of vital healthcare services to patients in the comfort of their homes.
LHC (LHCG) Up 0.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
LHC (LHCG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LHC Group (LHCG) to Expand Access in Georgia With New Buyout
by Zacks Equity Research
LHC Group (LHCG) is set to acquire Georgia-based Three Rivers Home Health that will expand its service footprint in 36 counties in the state of Georgia.
LHC Group (LHCG) Q2 Earnings & Revenues Miss Estimates
by Zacks Equity Research
LHC Group's (LHCG) second-quarter results benefit from organic growth in hospice admissions. However, home health admissions decline organically.
LHC Group (LHCG) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
LHC (LHCG) delivered earnings and revenue surprises of -25.76% and 3.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights McKesson, AmerisourceBergen, LHC Group and Glaukos
by Zacks Equity Research
McKesson, AmerisourceBergen, LHC Group and Glaukos are part of Zacks top Analyst Blog.
Medical Device Stocks' Earnings on Aug 3: MCK, ABC & More
by Indrajit Bandyopadhyay
Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how MCK, ABC, LHCG and GKOS fare this time.
Here's Why You Should Retain LHC Group (LHCG) Stock Now
by Zacks Equity Research
LHC Group (LHCG) continues to benefit from strategic deals and a broad array of services.
Factors that Make UnitedHealth Group (UNH) an Attractive Bet Now
by Zacks Equity Research
UnitedHealth Group (UNH) continues to benefit from sustained top-line growth, a growing membership, and a strong cash position.
LHC Group (LHCG) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
LHC Group's (LHCG) first-quarter results benefit from organic growth in both home health as well as hospice admissions.
LHC Group (LHCG) Q1 Earnings Surpass Estimates
by Zacks Equity Research
LHC (LHCG) delivered earnings and revenue surprises of 3.81% and 0.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth (UNH) to Spend $5.4B on Home-Health Profile Boost
by Zacks Equity Research
UnitedHealth (UNH) intends to combine its Optum business with LHC Group to expand its reach in the healthcare-at-home market.
LHC Group's (LHCG) Deal With Optum to Boost Value-Based Care
by Zacks Equity Research
LHC Group's (LHCG) deal with Optum is likely to enhance and extend value-based care to patients' homes.
Company News for Mar 30, 2022
by Zacks Equity Research
Companies In The News Are: FDX, UNH, LHCG, MRNA, ESLT.
LHC (LHCG) Moves 5.9% Higher: Will This Strength Last?
by Zacks Equity Research
LHC (LHCG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LHC Group (LHCG) Ties Up to Improve Home Health Services
by Zacks Equity Research
LHC Group's (LHCG) latest joint venture with Archbold Medical Center to enhance home health services in Thomasville and across South Georgia.
LHC Group (LHCG) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Despite the weak bottom-line performance, LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health admissions.
LHC Group (LHCG) Q4 Earnings Lag Estimates
by Zacks Equity Research
LHC (LHCG) delivered earnings and revenue surprises of -4.55% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain LHC Group (LHCG) Stock Now
by Zacks Equity Research
LHC Group (LHCG) continues to benefit from strategic deals and a broad array of services.
LHC (LHCG) Down 15.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
LHC (LHCG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LHC Group (LHCG) Q3 Earnings Match Estimates, Down Y/Y
by Zacks Equity Research
LHC Group's (LHCG) third-quarter results benefit from organic growth in both home health and hospice admissions.